262 results on '"Woessmann W"'
Search Results
2. Leukämien und Lymphome
3. Improving outcomes of childhood and young adult non-Hodgkin lymphoma (NHL); twenty-five years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL)
4. NON-HODGKIN LYMPHOMA PRESENTING WITH SPINAL CORD COMPRESSION: A POPULATION-BASED ANALYSIS ON THE NHL-BFM STUDY GROUP
5. VARIANT ALK-FUSION POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL): A POPULATION-BASED COHORT OF THE NHL-BFM STUDY GROUP
6. PDGFRβ DRIVES PROGRESSION BY ONCOGENE TRANSCRIPTION THROUGH STAT3/STAT5 HYPERACTIVATION IN ALCL
7. CHARACTERIZATION OF IG-MYC-BREAKPOINTS AND THEIR APPLICATION FOR QUANTITATIVE MINIMAL DISEASE MONITORING IN HIGH-RISK PEDIATRIC BURKITT-LYMPHOMA AND –LEUKEMIA
8. COMBINATION TREATMENT WITH VINBLASTINE AND CRIZOTINIB IN PEDIATRIC ANAPLASTIC LARGE CELL LYMPHOMA
9. MOLECULAR GENETICS ANALYSIS OF B-CELL PRECURSOR LYMPHOMA IN PEDIATRIC AND ADOLESCENT PATIENTS REVEALS HIGH FREQUENCY OF KMT2A TRANSLOCATIONS
10. Allogeneic-matched sibling stem cell transplantation in a 13-year-old boy with ataxia telangiectasia and EBV-positive non-Hodgkin lymphoma
11. IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma
12. Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE
13. No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients
14. Subcutaneous panniculitis-like T-cell lymphoma in children: a detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome
15. Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis
16. Molecular features of non-anaplastic peripheral T-cell lymphoma in children and adolescents
17. Treatment and Outcome Analysis of 639 Relapsed Non-Hodgkin Lymphomas in Children and Adolescents and Resulting Treatment Recommendations
18. Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols
19. CLINICAL IMPACT OF POST-TRANSPLANT CHIMERISM MONITORING IN CD33/34 BONE MARROW SUBPOPULATIONS AND WHOLE PERIPHERAL BLOOD IN PEDIATRIC AML: PROSPECTIVE COMPARISON OF HIGHLY SENSITIVE REAL TIME SEQUENCE POLYMORPHISM PCR VERSUS GOLD-STANDARD STR-PCR: PH-O097
20. Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents
21. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning
22. Inactivation of the ARF–MDM-2–p53 pathway in sporadic Burkitt's lymphoma in children
23. Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria
24. Fludarabin, treosulfan, thiotepa, and alemtuzumab as conditioning regimen for children with haemophagocytic lymphohistiocytosis: low toxicity and effective disease control: O168
25. Risk-adapted therapy for patients with relapsed or refractory ALCL - interim-results of the prospective EICNHL-Trial ALCL-relapse: 74
26. Re-induction approaches to relapsed/refractory childhood and adolescent non Hodgkinʼs lymphoma: BFM perspective: 71
27. Biologically based risk factors in ALCL: minimal disease and immune response against ALK: 28
28. Pretreatment plasma cytokine levels in children with anaplastic large cell lymphoma: 32
29. Immunotherapy with FBTA05 (Bi20), a trifunctional anti-CD3 x anti-CD20 antibody in recurrent childhood B-cell malignancies: P858
30. Intensified pre-emptive immunotherapy in childhood acute myeloid leukaemia patients showing evidence of mixed chimerism after allogeneic stem cell transplantation: O171
31. Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency
32. Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents
33. SAFETY AND EFFICACY OF THERAPEUTIC EARLY-ONSET GRANULOCYTE TRANSFUSIONS IN PEDIATRIC PATIENTS WITH NEUTROPENIA AND SEVERE INFECTIONS: 2PS-02-04
34. 103 - NON-HODGKIN LYMPHOMA PRESENTING WITH SPINAL CORD COMPRESSION: A POPULATION-BASED ANALYSIS ON THE NHL-BFM STUDY GROUP
35. 115 - PDGFRβ DRIVES PROGRESSION BY ONCOGENE TRANSCRIPTION THROUGH STAT3/STAT5 HYPERACTIVATION IN ALCL
36. 111 - COMBINATION TREATMENT WITH VINBLASTINE AND CRIZOTINIB IN PEDIATRIC ANAPLASTIC LARGE CELL LYMPHOMA
37. 052 - MOLECULAR GENETICS ANALYSIS OF B-CELL PRECURSOR LYMPHOMA IN PEDIATRIC AND ADOLESCENT PATIENTS REVEALS HIGH FREQUENCY OF KMT2A TRANSLOCATIONS
38. 041 - VARIANT ALK-FUSION POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL): A POPULATION-BASED COHORT OF THE NHL-BFM STUDY GROUP
39. 040 - IMMUNOGLOBULIN SUBCLASSES OF ANTI-ALK ANTIBODIES IN PEDIATRIC ANAPLASTIC LARGE CELL LYMPHOMA
40. 028 - CHARACTERIZATION OF IG-MYC-BREAKPOINTS AND THEIR APPLICATION FOR QUANTITATIVE MINIMAL DISEASE MONITORING IN HIGH-RISK PEDIATRIC BURKITT-LYMPHOMA AND –LEUKEMIA
41. Treatment of relapsed acute myelogeneous leukaemia with MLL/AF6 fusion after stem cell transplantation by intensive reinduction followed by adoptive immunotherapy
42. 17. Paediatric Lymphomas: 090 SALVAGE STRATEGY FOR ANAPLASTIC LARGE CELL LYMPHOMA IN CHILDREN: PROGNOSTIC IMPACT OF TIME OF RELAPSE AND CD3 REACTIVITY
43. Large B-cell lymphomas with ALK-rearrangement display a different genetic and epigenetic profile than diffuse large B-cell lymphoma
44. Clinical and Genetic Risk Factors Define Two Risk Groups of Extracranial Rhabdoid Tumors: A Plea for High Risk Tailored Therapies
45. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH REDUCED‐TOXICITY CONDITIONING FOR PEDIATRIC RELAPSED OR REFRACTORY ALK‐POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA.
46. MINIMAL DISSEMINATED AND MINIMAL RESIDUAL DISEASE IN CHILDHOOD AND ADOLESCENT NON‐HODGKIN LYMPHOMA.
47. Results and conclusions of the European intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma
48. Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma
49. No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients
50. Non-Hodgkin lymphoma and pre-existing conditions: Spectrum, clinical characteristics and outcome in 213 children and adolescents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.